Zacks Research Analysts Reduce Earnings Estimates for BMRN
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Zacks Research cut their Q2 2026 earnings estimates for shares of BioMarin Pharmaceutical in a research report issued on Wednesday, March 19th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will earn $0.99 per share for the quarter, down from their prior forecast of […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) – Zacks Research cut their Q2 2026 earnings estimates for shares of BioMarin Pharmaceutical in a research report issued on Wednesday, March 19th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will earn $0.99 per share for the quarter, down from their prior forecast of […]
